Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 6-K | 6-K |
| Revenues: |
| Specialty Pharmacy One | 60.3 | | | | | | |
| Other | 0.1 | 0.1 | 0.1 | 0.1 | | | |
| Customer One | 60.3 | 25.5 | | | | | |
| Customer Two | 46.9 | 19.6 | | | | | |
| Other | | 0.3 | 50.0 | 0.2 | | | |
| Total revenues [+] | 134.0 | 45.6 | 50.1 | 0.3 | 0.5 | 0.4 | 0.2 |
| Licensing | | | | | | 0.4 | 0.1 |
| Royalties | | | | | | 33.9 | 14.5 |
| Revenue growth [+] | 193.9% | -9.0% | 15660.4% | -31.3% | 10.8% | 141.6% | |
| Other | -23.9% | -0.8% | 0.0% | | | | |
| Customer One | 136.2% | | | | | | |
| Customer Two | 139.2% | | | | | | |
| United States | 125.2% | | | -42.0% | | | |
| Cost of goods sold | 5.7 | 1.1 | 0.0 | 0.0 | 0.0 | 47.3 | 25.2 |
| Gross profit | 128.4 | 44.5 | 50.1 | 0.3 | 0.5 | -46.9 | -25.0 |
| Gross margin | 95.8% | 97.6% | 100.0% | 100.0% | 100.0% | -11212.4% | -14466.5% |
| Selling, general and administrative [+] | 196.4 | 173.5 | 97.3 | 22.3 | 13.7 | -0.2 | 2.2 |
| General and administrative | 196.4 | 173.5 | 97.3 | 22.3 | 13.7 | | |
| Research and development | 45.0 | 51.1 | 50.3 | 52.9 | 41.4 | | |
| Other operating expenses | -1.5 | 0.6 | 6.8 | 14.9 | -0.7 | | |
| EBITDA [+] | -108.8 | -178.0 | -102.9 | -89.8 | -53.9 | -46.7 | -27.2 |
| EBITDA growth | -38.9% | 72.9% | 14.6% | 66.5% | 15.5% | 71.3% | |
| EBITDA margin | -81.1% | -390.3% | -205.4% | -28230.2% | -11647.3% | -11165.6% | -15745.7% |
| Depreciation | 0.6 | 0.7 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBITA | -109.4 | -178.6 | -103.0 | -89.8 | -53.9 | -46.7 | -27.3 |
| EBITA margin | -81.6% | -391.7% | -205.5% | -28240.6% | -11651.6% | -11170.8% | -15758.4% |
| Amortization of intangibles | 2.1 | 2.1 | 1.3 | 1.1 | 1.3 | | |
| EBIT [+] | -111.5 | -180.7 | -104.3 | -90.9 | -55.2 | -46.7 | -27.3 |
| EBIT growth | -38.3% | 73.3% | 14.7% | 64.6% | 18.3% | 71.3% | |
| EBIT margin | -83.2% | -396.3% | -208.1% | -28598.4% | -11930.9% | -11170.8% | -15758.4% |
| Interest income | 5.1 | 0.5 | 1.5 | 2.7 | 2.2 | | |
| Interest income | 5.1 | 0.5 | 1.5 | 2.7 | 2.2 | | |
| Other income (expense), net | | | | | | -24.1 | 4.0 |
| Pre-tax income | -106.4 | -180.2 | -102.8 | -88.2 | -53.0 | -70.8 | -23.3 |
| Income taxes | 1.8 | 0.8 | -0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Tax rate | | | 0.1% | | | 0.0% | 0.0% |
| Net income | -108.2 | -181.0 | -102.7 | -88.4 | -53.1 | -70.8 | -23.3 |
| Net margin | -80.7% | -396.8% | -204.9% | -27794.0% | -11464.1% | -16935.9% | -13465.3% |
| |
| Basic EPS [+] | ($0.76) | ($1.40) | ($0.87) | ($0.95) | ($0.63) | ($0.92) | ($0.66) |
| Growth | -45.5% | 61.4% | -8.8% | 51.8% | -32.0% | 39.4% | |
| Diluted EPS [+] | ($0.76) | ($1.40) | ($0.87) | ($0.95) | ($0.63) | ($0.92) | ($0.66) |
| Growth | -45.5% | 61.4% | -8.8% | 51.8% | -32.0% | 39.4% | |
| |
| Shares outstanding (basic) [+] | 141.9 | 129.4 | 118.5 | 93.0 | 84.8 | 76.9 | 35.3 |
| Growth | 9.7% | 9.2% | 27.4% | 9.7% | 10.2% | 117.9% | |
| Shares outstanding (diluted) [+] | 141.9 | 129.4 | 118.5 | 93.0 | 84.8 | 76.9 | 35.3 |
| Growth | 9.7% | 9.2% | 27.4% | 9.7% | 10.2% | 117.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|